Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: Part II
Author:
- 1 November 2004
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 22 (6) , 472-477
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Risk of Cancer in Users of StatinsJournal of Clinical Oncology, 2004
- Cholesterol and prostate cancerJournal of Cellular Biochemistry, 2003
- Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective StudyJournal of Women's Health, 2003
- Inhibition of cdk2 Activating Phosphorylation by MevastatinJournal of Biological Chemistry, 2003
- Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cellsClinical & Experimental Metastasis, 2002
- Atherosclerosis gene increases susceptibility to prostate cancerThe Lancet, 2002
- Selenium and vitamin E supplements for prostate cancer: evidence or embellishment?Urology, 2002
- Causes of Death in Elderly Prostate Cancer Patients and in a Comparison Nonprostate Cancer CohortJNCI: Journal of the National Cancer Institute, 2000
- The hypocholesterolemic activity of orally administered polyene macrolides.Proceedings of the National Academy of Sciences, 1968
- On the occurrence of crystals in tumoursThe Journal of Pathology and Bacteriology, 1909